Analytical Data
-
基因名
Galectin-14/LGALS14
-
简介
PPL13/LGALS14 is a mammalian placenta-specific galectin with placental specificity. Many placental lectins induce apoptosis of activated T cells and other leukocytes, thereby conferring immune tolerance to the recipient. Galectin-14/LGALS14 Protein, Human (HEK293, His) is the recombinant human-derived Galectin-14/LGALS14 protein, expressed by HEK293 , with C-6*His labeled tag.
- Application
-
别名
rHuPlacental protein 13-like/LGALS14, His; Placental Protein 13-Like; Charcot-Leyden Crystal Protein 2; CLC2; Galectin-14; Gal-14; LGALS14; PPL13
-
种属
Human
-
表达系统
HEK293
-
标签
C-6*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
AAH22257.1
-
表达区间
M1-D139
-
蛋白长度
Full Length
-
分子量
16 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Galectin-14, also known as LGALS14, is a member of the galectin family of proteins, which are beta-galactoside-binding lectins with significant roles in various biological processes, including cell adhesion, immune response, and apoptosis. Research on Galectin-14 has gained interest due to its involvement in reproductive biology and potential implications in pregnancy, such as embryo implantation and trophoblast interaction with the maternal environment. It is predominantly expressed in the female reproductive system, particularly during the early stages of gestation. The study of recombinant Galectin-14 protein is crucial for elucidating its molecular mechanisms and understanding its functional roles. By producing Galectin-14 in a recombinant form, researchers aim to investigate its binding properties, structure-function relationships, and interactions with glycosylated ligands. This can lead to insights into its potential therapeutic applications, including its role in fertility treatments and managing pregnancy-related complications. Additionally, elucidating the pathway regulated by Galectin-14 can enhance our understanding of its contribution to reproductive health and may uncover novel targets for clinical intervention. Overall, the study of recombinant LGALS14 holds promise for advancing knowledge in reproductive biology and developing therapeutic strategies for related disorders.
